The Peptide Wiki
Mapping Knowledge.
Advancing Discovery.
Last updated
Peptide Profile

Spironolactone: Research, Dosing, and Where to Buy in 2026

A research-first profile for Spironolactone, aggregating mechanism notes, transcript dosing mentions, vendor recommendations, and PubMed-indexed literature without presenting medical guidance.

⚕️ US PRESCRIPTION REQUIRED. Spironolactone is a prescription medication in the United States. Prescription and controlled-substance rules differ by country, so check your local laws before any purchase or use. Information on this page is educational and not medical advice. Consult a licensed prescribing physician.
Quick Answer

Spironolactone is a research compound profiled here from named-expert transcripts and peer-reviewed literature, without medical guidance. As of July 2026, The Peptide Wiki aggregates 8 PubMed-cited papers for Spironolactone, each linked to its source.

Key Facts
Pharmaceutical
  • 0 aggregated dosing-protocol mentions from source transcripts.
  • 8 PubMed-indexed citations listed in the research table below.
  • 0 vendor recommendations captured from named experts.
Sourced to expert
Check vendor COA
Verify dose w/ clinician

What is Spironolactone?

Research compound aggregated from creator and literature mentions. No direct disease-treatment claims are made on this page.

Spironolactone Dosing Protocols

The entries below are transcript-derived dosing mentions. They are preserved for research context and are not medical advice.

No transcript-derived dosing mentions in current source set.

Where to Buy Spironolactone in 2026

No tracked vendor recommendations for Spironolactone yet. See our vendor directory.

Side Effects and Safety

Anecdotal reports and study-level observations vary by route, dose, and individual. This page does not provide medical advice. Consult a qualified clinician before any research use.

User Reviews

User reviews aggregator coming Q3 2026 (Reddit + YouTube comments + Discord research notes). Until then, see the expert quote section above and PubMed citations below.

Research Efficacy Snapshot

Published efficacy percentages cited in PubMed trials and named-expert reports about Spironolactone. Each line links to the original source.

  • "The RALES clinical trial was stopped early when it was shown that there was a 30% reduction in risk of death among the spironolactone patients." · Doggrell S et al, 2001 PubMed

Research and Studies

8 PubMed-indexed papers reference Spironolactone. Top 8 shown.

PMID 7009396
IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans
1980

Frequently Asked Questions

Is Spironolactone FDA-approved?

Spironolactone is presented on this page as a research compound. FDA approval status, scheduling, and state-specific rules may apply and change. Verify current regulatory status before any decision.

How much research has been published on Spironolactone?

8 PubMed-indexed paper(s) reference Spironolactone in our current research feed. See the Research and Studies section above for citations.